I'm trying to vette the stock before I throw more money into it without using CTIX sources. I remain very skeptical of because honestly they post a PR for very bizarre things. Can you find non-CTIX sources to confirm any of their claims ever?
Also as for the insider's owning bit they could just be pumping to a certain level to throw off their own shares. Now I'm not saying this IS the case, but it is certainly possible. Not to mention, has anyone considered the possibility of dilution?
I get that the study is done at Beth Israel and that's certainly a prestigious institution but we must not conflate prestige with merit here. I mean can't anyone with the right amount of money put up trials there? I don't think the institution itself should be indicator of the outcome for Kevetrin.
And I mean, what does "tumor shrinkage" mean. Did it shrink 1%? Did it shrink to a point where this could realistically combat cancer? I'm looking for indications, even in a preclinical sense, that this actually works.
This is my last post for the day so I'd like to ask: What are everyone's high point share projections if this does end up working?